Why Modern Enterprises Choose Drupal
More Than a CMS. A Composable Digital Experience Platform.
When your digital needs outgrow basic templates and rigid systems, you need a platform engineered for flexibility, scalability, and integration. Drupal is the open-source powerhouse chosen by global enterprises to build digital experiences that are secure, adaptable, and built to last.
Recent releases
|
Doctor Engagement Metric Driving Real Impact in Pharma
Doctor Engagement Metric is the crucial KPI for pharma, linking campaigns to prescriptions by tracking meaningful interactions and building long term trust.
|
Field Force 2.0: Turning 10,000 Reps Into Digital-First Growth Drivers
The End of the Old PlaybookFor decades, pharma believed the field force was the growth engine. Hire more reps. Train them harder. Push for more calls. It worked, until it didn’t.Doctors today don’t…
|
Personalized Patient Support Driving Better Pharma Outcomes
Personalized Patient Support transforms pharma PSPs by focusing on language, context, and patient journeys, improving adherence, trust, and measurable outcomes.
|
Pharma Marketing KPIs Shaping the Future of Engagement
Pharma marketing KPIs should measure outcomes like doctor engagement, prescription uptake, and patient adherence to deliver growth and boardroom credibility.
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
